The Abbott RealTime HCV Genotype II.

Abbott RealTime HCV Genotype II assay receives FDA approval FDA approves first genotyping check for individuals with hepatitis C virus The U.S. Food and Drug Administration today approved a test that identifies the genotype of hepatitis C virus a individual is holding online-apotek . The Abbott RealTime HCV Genotype II, which can differentiate genotypes 1, 1a, 1b, 2, 3, 4, and 5,using a sample of an infected patient's blood serum or plasma, will aid health care experts in determining the correct approach to treatment. Because the different HCV genotypes respond in different ways to available drug treatments, knowing the type of HCV one is infected with can lead to better individual outcomes. Tests like this one can help doctors gain a knowledge of a patient's HCV position,&quot stated Alberto Gutierrez, Ph.D., director of any office of In Vitro Diagnostics and Radiological Wellness in FDA's Center for Products and Radiological Health.